SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-053569
Filing Date
2022-04-29
Accepted
2022-04-29 16:15:53
Documents
6
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm223584d2_def14a.htm DEF 14A 1098376
2 GRAPHIC tm223584d1_pre14aimg0001.jpg GRAPHIC 10861
3 GRAPHIC tm223584d1_pre14asp4img02.jpg GRAPHIC 3248
4 GRAPHIC tm223584d1_pre14asp4img03.jpg GRAPHIC 3791
5 GRAPHIC tm223584d1_pre14acvr01.jpg GRAPHIC 191109
6 GRAPHIC tm223584d1_pre14acvr02.jpg GRAPHIC 132489
  Complete submission text file 0001104659-22-053569.txt   1570461
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36294 | Film No.: 22875651
SIC: 2834 Pharmaceutical Preparations